Sterilisation device to undergo US Phase II trials:
This article was originally published in Clinica
Conceptus is to begin US Phase II clinical trials of its S/TOP device for permanent contraception. The effectiveness of the selective tubal occlusion procedure device, which is deployed permanently into each fallopian tube, will be assessed in an initial study of 15 patients. The company, based in San Carlos, California, began its first Phase II clinical trial of the device at a single site in Australia last year.